SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWorsley Inv Ltd Regulatory News (WINV)

Share Price Information for Worsley Inv Ltd (WINV)

Share Price is delayed by 15 minutes
Get Live Data
26.40    -1.10 (-4.00%)
Bid:
25.00
Ask:
27.80
Spread: 2.80 (11.20%)
Market Cap: £9.28m
WINV Live PriceLast checked at - London Stock Exchange

Intraday Worsley Inv Ltd Share Chart

Director/PDMR Dealing

24 Jul 2025 07:00

RNS Number : 3127S
Worsley Investors Limited
24 July 2025
 

24 July 2025

 

Worsley Investors Limited

 (the "Company")

 

(a closed-ended investment company incorporated with limited liability under the laws of Guernsey with registered number 43007)

Director / PDMR Dealing

 

The Company announces that William Scott, a Non-Executive Director of the Company, has acquired ordinary shares of no par value in the capital of the Company ("Ordinary Shares"), as follows:

 

Director/PDMR

Previous Ordinary Shares held

Ordinary Shares Acquired

 

Price per Ordinary Share (GBP)

Total Holding following Purchase

% of the Company's voting rights in issue

William Scott

 

1,000,000

50,000

0.24664

1,050,000

3.11%

 

The relevant notifications set out below are provided in accordance with the requirements of the Market Abuse Regulation.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

William Scott

2

 

Reason for the notification

 

a)

 

Position/status

 

 

Non-Executive Director

b)

 

Initial notification /Amendment

 

 

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

 

Worsley Investors Limited

b)

 

LEI

 

 

213800AF85VEZMDMF931

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

 

Ordinary Shares of no par value

 

 

GG00BHXH0C87 

b)

 

Nature of the transaction

 

Purchase

c)

 

Price(s) and volume(s)

 

 

 

Price(s)

 

Volume(s)

£0.24664

50,000

d)

 

Aggregated information

 

- Aggregated volume

- Price

 

 

 

50,000

£12,332.00

e)

 

Date of the transaction

 

22 July 2025

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE, (XLON)

 

 

For further information, please contact:

 

Worsley Associates LLP (Investment Advisor)

Blake NixonTel: +44 (0) 203 873 2288

 

Shore Capital (Financial Adviser and Broker)

Anita Ghanekar / Harry Davies-BallTel: +44 (0) 20 74080 4090

 

Apex Fund and Corporate Services (Guernsey) Limited (Administrator and Secretary)

Matt Lihou / Aoife BennettTel: +44 (0) 20 3530 3687

 

LEI: 213800AF85VEZMDMF931

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUOVNRVAUBUAR
Date   Source Headline
23rd Sep 20112:45 pmRNSHolding(s) in Company
5th Aug 201111:24 amRNSDividend Declaration
5th Aug 201111:21 amRNSNet Asset Value(s)
4th Jul 20117:00 amRNSPortfolio Update
4th Jul 20117:00 amRNSRefinancing
22nd Jun 20114:03 pmRNSHolding(s) in Company
19th May 20117:00 amRNSInterim Management Statement
5th May 20114:37 pmRNSDisposal
5th May 20113:43 pmRNSDividend Declaration
6th Apr 20114:38 pmRNSNational Storage Mechanism
1st Apr 20114:35 pmRNSRefinancing
1st Apr 20112:06 pmRNSPortfolio Update
8th Mar 201111:29 amRNSHolding(s) in Company
28th Feb 20114:30 pmRNSHalf Yearly Report
7th Feb 20112:51 pmRNSHolding(s) in Company
7th Feb 201111:49 amRNSHolding(s) in Company
2nd Feb 20117:00 amRNSNet Asset Value(s)
1st Feb 201110:15 amRNSDividend Declaration
31st Jan 20111:00 pmRNSHolding(s) in Company
24th Jan 201110:44 amRNSHolding(s) in Company
4th Jan 20117:00 amRNSPortfolio Update
16th Dec 20102:23 pmRNSResult of AGM
11th Nov 20101:16 pmRNSHolding(s) in Company
9th Nov 20107:00 amRNSInterim Management Statement
8th Nov 201011:34 amRNSAnnual Information Update
5th Nov 20101:40 pmRNSNotice of AGM
3rd Nov 201012:44 pmRNSDividend Declaration
22nd Oct 201012:10 pmRNSAnnual Financial Report
22nd Oct 201012:10 pmRNSAnnual Financial Report
1st Oct 201011:00 amRNSPortfolio Update
1st Oct 20107:00 amRNSRefinancing
19th Aug 20107:00 amRNSNet Asset Value(s)
5th Aug 201011:40 amRNSDividend Declaration
1st Jul 20107:00 amRNSPortfolio Update
23rd Jun 201011:01 amRNSDirector/PDMR Shareholding
19th May 20109:59 amRNSInterim Management Statement
5th May 20104:56 pmRNSDividend Declaration
1st Apr 20107:00 amRNSPortfolio Update
15th Mar 201012:05 pmRNSHolding(s) in Company
26th Feb 201012:35 pmRNSHalf Yearly Report
9th Feb 20107:00 amRNSNet Asset Value(s)
3rd Feb 201010:00 amRNSInterim Dividend
5th Jan 20107:00 amRNSPortfolio Update
17th Dec 20093:13 pmRNSResult of AGM
15th Dec 20097:00 amRNSLease Agreement
26th Nov 200911:13 amRNSHolding(s) in Company
25th Nov 20097:00 amRNSAnnual Information Update
5th Nov 20097:00 amRNSDividend Declaration
5th Nov 20097:00 amRNSInterim Management Statement
26th Oct 20097:00 amRNSAnnual Financial Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.